| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.47▲ | 2.45▲ | 2.46▲ | 2.49▲ | 2.54▼ |
| MA10 | 2.46▲ | 2.46▲ | 2.47▲ | 2.54▼ | 2.48▲ |
| MA20 | 2.46▲ | 2.47▲ | 2.47▲ | 2.53▼ | 2.54▼ |
| MA50 | 2.46▲ | 2.48▼ | 2.52▼ | 2.50▼ | 2.63▼ |
| MA100 | 2.47▲ | 2.52▼ | 2.60▼ | 2.54▼ | 3.77▼ |
| MA200 | 2.47▲ | 2.58▼ | 2.46▲ | 2.48▲ | 6.50▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.000▼ | 0.003▲ | -0.017▼ | 0.014▲ |
| RSI | 71.608▲ | 51.879▲ | 47.428▼ | 48.686▼ | 47.978▼ |
| STOCH | 73.889 | 42.222 | 49.444 | 10.906▼ | 35.066 |
| WILL %R | -16.667▲ | -33.333 | -33.333 | -85.417▼ | -66.667 |
| CCI | 165.145▲ | 2.600 | 5.128 | -94.175 | -31.382 |
|
Thursday, November 27, 2025 01:09 AM
Eventbrite's cost-cutting drives growth, but declining revenue and competition raise risks. Click here to read why investors should avoid EB stock now.
|
|
Thursday, November 06, 2025 03:35 PM
Eventbrite (EB) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.04 per share a year ago. These figures are ...
|
|
Tuesday, September 16, 2025 05:45 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/11/25 | 2.42 | 2.49 | 2.42 | 2.49 | 244,487 |
| 26/11/25 | 2.45 | 2.50 | 2.45 | 2.46 | 382,117 |
| 25/11/25 | 2.44 | 2.50 | 2.44 | 2.46 | 289,523 |
| 24/11/25 | 2.56 | 2.575 | 2.45 | 2.45 | 416,125 |
| 21/11/25 | 2.51 | 2.585 | 2.49 | 2.58 | 516,229 |
| 20/11/25 | 2.59 | 2.6123 | 2.495 | 2.51 | 610,534 |
| 19/11/25 | 2.60 | 2.635 | 2.515 | 2.56 | 510,388 |
| 18/11/25 | 2.60 | 2.64 | 2.56 | 2.60 | 404,286 |
| 17/11/25 | 2.65 | 2.67 | 2.595 | 2.63 | 402,468 |
| 14/11/25 | 2.73 | 2.735 | 2.62 | 2.69 | 535,237 |
|
|
||||
|
|
||||
|
|